Patents by Inventor Thomas Malone

Thomas Malone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6765012
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Grant
    Filed: September 27, 2002
    Date of Patent: July 20, 2004
    Assignee: Allergan, Inc.
    Inventors: Steven W. Andrews, Julie A. Wurster, Edward H. Wang, Thomas Malone
  • Patent number: 6747025
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell poliferation.
    Type: Grant
    Filed: March 13, 2003
    Date of Patent: June 8, 2004
    Assignee: Allergan, Inc.
    Inventors: Steven W. Andrews, Michael E. Garst, Xialing Guo, Jonathan J. Hebert, Thomas Malone, Julie A. Wurster, Clarence Eugene Hull, III
  • Publication number: 20040102509
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Application
    Filed: March 13, 2003
    Publication date: May 27, 2004
    Applicant: Allergan, Inc.
    Inventors: Steven W. Andrews, Michael E. Garst, Xialing Guo, Jonathan J. Hebert, Thomas Malone, Julie A. Wurster, Clarence Eugene Hull
  • Publication number: 20040019098
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Application
    Filed: April 1, 2003
    Publication date: January 29, 2004
    Applicant: Allergan, Inc.
    Inventors: Steven W. Andrews, Xialing Guo, Zhen Zhu, Clarence E. Hull, Julie A. Wurster, Shimiao Wang, Edward H. Wang, Thomas Malone
  • Publication number: 20030199478
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Application
    Filed: September 27, 2002
    Publication date: October 23, 2003
    Inventors: Steven W. Andrews, Julie A. Wurster, Edward H. Wang, Thomas Malone
  • Patent number: 6541504
    Abstract: The present invention relates to organic molecules capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation.
    Type: Grant
    Filed: April 3, 2002
    Date of Patent: April 1, 2003
    Assignee: Allergan Sales, LLC
    Inventors: Steven W. Andrews, Julie A. Wurster, Clarence E. Hull, III, Edward H. Wang, Thomas Malone, Xialing Guo, Zhen Zhu
  • Patent number: 3966986
    Abstract: A method for enhancing the flavor and aroma of a final tea beverage prepared from a soluble tea, e.g., a concentrated tea extract or a dried soluble tea, by adding a flavoring agent to the soluble tea to produce a final tea beverage containing about 0.01-25 ppm of the added flavoring agent. The flavoring agent, having different preferred compositions for cold and hot-water soluble products, includes up to 39 selected flavoring constituents in specified amounts.
    Type: Grant
    Filed: October 29, 1974
    Date of Patent: June 29, 1976
    Assignee: Tenco Brooke Bond Limited
    Inventors: George L. K. Hunter, Victor Krampl, Charles Thomas Malone, Gerald Edward Usher